BACKGROUND: Fractional exhaled nitric oxide (FeNO) has been proposed as a biomarker of airway inflammation for cohort studies of asthma. OBJECTIVES: To assess the association between FeNO and asthma symptoms among 7-year-old children living in an inner-city community. To test the association between environmental tobacco smoke (ETS) exposure (previous and current) and FeNO among these children. METHODS: As part of a longitudinal study of asthma, children recruited in Head Start centers at age 4 had offline FeNO and lung function testing at age 7. Children with allergen-specific immunoglobulin E (IgE) (≥0.35 IU/mL) at age 7 were considered seroatopic. ETS exposure at ages 4 and 7 was assessed by questionnaire. RESULTS: Of 144 participating children, 89 had complete questionnaire data and achieved valid FeNO and lung function tests. Children with reported wheeze in the previous 12 months (n = 19) had higher FeNO than those without wheeze (n = 70) (geometric means 17.0 vs. 11.0 ppb, p = .005). FeNO remained significantly associated with wheeze (p = .031), after adjusting for seroatopy and forced expiratory volume in 1 second (FEV₁) in multivariable regression. FeNO at age 7 was positively associated with domestic ETS exposure at age 4 (29%) (β = 0.36, p = .015) but inversely associated with ETS exposure at age 7 (16%) (β = -0.74, p < .001). CONCLUSIONS: Given its association with current wheeze, independent of seroatopy and lung function, FeNO provides a relevant outcome measure for studies in inner-city communities. While compelling, the positive association between ETS exposure at age 4 and a marker of airway inflammation at age 7 should be confirmed in a larger study.
BACKGROUND: Fractional exhaled nitric oxide (FeNO) has been proposed as a biomarker of airway inflammation for cohort studies of asthma. OBJECTIVES: To assess the association between FeNO and asthma symptoms among 7-year-old children living in an inner-city community. To test the association between environmental tobacco smoke (ETS) exposure (previous and current) and FeNO among these children. METHODS: As part of a longitudinal study of asthma, children recruited in Head Start centers at age 4 had offline FeNO and lung function testing at age 7. Children with allergen-specific immunoglobulin E (IgE) (≥0.35 IU/mL) at age 7 were considered seroatopic. ETS exposure at ages 4 and 7 was assessed by questionnaire. RESULTS: Of 144 participating children, 89 had complete questionnaire data and achieved valid FeNO and lung function tests. Children with reported wheeze in the previous 12 months (n = 19) had higher FeNO than those without wheeze (n = 70) (geometric means 17.0 vs. 11.0 ppb, p = .005). FeNO remained significantly associated with wheeze (p = .031), after adjusting for seroatopy and forced expiratory volume in 1 second (FEV₁) in multivariable regression. FeNO at age 7 was positively associated with domestic ETS exposure at age 4 (29%) (β = 0.36, p = .015) but inversely associated with ETS exposure at age 7 (16%) (β = -0.74, p < .001). CONCLUSIONS: Given its association with current wheeze, independent of seroatopy and lung function, FeNO provides a relevant outcome measure for studies in inner-city communities. While compelling, the positive association between ETS exposure at age 4 and a marker of airway inflammation at age 7 should be confirmed in a larger study.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: M S Perzanowski; S M Canfield; G L Chew; R B Mellins; L A Hoepner; J S Jacobson; I F Goldstein Journal: Clin Exp Allergy Date: 2008-03-18 Impact factor: 5.018
Authors: J S Jacobson; R B Mellins; R Garfinkel; A G Rundle; M S Perzanowski; G L Chew; H F Andrews; I F Goldstein Journal: Allergy Date: 2008-01 Impact factor: 13.146
Authors: Bian Liu; Kyung Hwa Jung; Megan K Horton; David E Camann; Xinhua Liu; Ann Marie Reardon; Matthew S Perzanowski; Hanjie Zhang; Frederica P Perera; Robin M Whyatt; Rachel L Miller Journal: Environ Int Date: 2012-08-28 Impact factor: 9.621
Authors: Allan C Just; Robin M Whyatt; Rachel L Miller; Andrew G Rundle; Qixuan Chen; Antonia M Calafat; Adnan Divjan; Maria J Rosa; Hanjie Zhang; Frederica P Perera; Inge F Goldstein; Matthew S Perzanowski Journal: Am J Respir Crit Care Med Date: 2012-08-23 Impact factor: 21.405
Authors: Elisabet Johansson; Lisa J Martin; Hua He; Xiaoting Chen; Matthew T Weirauch; John W Kroner; Gurjit K Khurana Hershey; Jocelyn M Biagini Journal: Clin Exp Allergy Date: 2021-02-13 Impact factor: 5.401
Authors: Watcharoot Kanchongkittiphon; Mark J Mendell; Jonathan M Gaffin; Grace Wang; Wanda Phipatanakul Journal: Environ Health Perspect Date: 2014-10-10 Impact factor: 9.031